Which drugs does patent 7,160,870 protect, and when does it expire?
Patent 7,160,870 protects PROMACTA and is included in two NDAs. There have been two Paragraph IV challenges on Promacta.
Protection for PROMACTA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has sixty-three patent family members in twenty-eight countries.